Cas:2653-64-7 (1Z)-1-(naphthalen-1-ylhydrazinylidene)naphthalen-2-one manufacturer & supplier

Chemical Name:(1Z)-1-(naphthalen-1-ylhydrazinylidene)naphthalen-2-one

CAS.NO:2653-64-7

Synonyms:Fat Bordeaux R;C.I. Solvent Red 4;Waxoline Red BN;Oil Dark Red;Pigment Bordeaux;Grasal Red;EINECS 220-176-4;C.I. Pigment Red 40;Pigment Red RLP;Fat Bordeaux

Molecular Formula:C₂₀H₁₄N₂O

Molecular Weight:298.33800

HS Code:2927000090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:500.6ºC at 760mmHg

Density:1.2g/cm3

Index of Refraction:1.662

PSA:44.95000

Exact Mass:298.11100

LogP:6.11400

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Fat Bordeaux R chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Fat Bordeaux physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Waxoline Red BN Use and application,C.I. Solvent Red 4 technical grade,usp/ep/jp grade.

Related News: Taiwan complained on Sunday that it was being punished because the World Health Organization considers it part of China, which has been subject to travel bans as the coronavirus spreads. (1Z)-1-(naphthalen-1-ylhydrazinylidene)naphthalen-2-one manufacturer Ultimately there’s likely a broad mix of social, cultural and economic drivers at play, suggested Lona Sandon, program director of the Department of Clinical Nutrition in the School of Health Professions at the UT Southwestern Medical Center in Dallas. She was not part of the research. (1Z)-1-(naphthalen-1-ylhydrazinylidene)naphthalen-2-one supplier South Korea and Japan are barring noncitizens who traveled recently to Hubei, the province at the center of the outbreak. (1Z)-1-(naphthalen-1-ylhydrazinylidene)naphthalen-2-one vendor As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. (1Z)-1-(naphthalen-1-ylhydrazinylidene)naphthalen-2-one factory Ultimately there’s likely a broad mix of social, cultural and economic drivers at play, suggested Lona Sandon, program director of the Department of Clinical Nutrition in the School of Health Professions at the UT Southwestern Medical Center in Dallas. She was not part of the research.